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Introduction: Recent studies have shown that vitamin-D intake can improve skeletal muscle function and strength in
frail vitamin-D insufficient individuals. We investigated whether vitamin-D intake can improve the muscular response to
resistance training in healthy young and elderly individuals, respectively.
Methods: Healthy untrained young (n = 20, age 20–30) and elderly (n = 20, age 60–75) men were randomized to
16 weeks of daily supplementary intake of either 48 μg of vitamin-D + 800 mg calcium (Vitamin-D-group) or 800 mg
calcium (Placebo-group) during a period and at a latitude of low sunlight (December-April, 56°N). During the last
12 weeks of the supplementation the subjects underwent progressive resistance training of the quadriceps muscle.
Muscle hypertrophy, measured as changes in cross sectional area (CSA), and isometric strength of the quadriceps were
determined. Muscle biopsies were analyzed for fiber type morphology changes and mRNA expression of vitamin-D
receptor (VDR), cytochrome p450 27B1 (CYP27B1) and Myostatin.
Results: In the vitamin-D groups, serum 25(OH)D concentration increased significantly and at week 12 was
significantly different from placebo in both young men (71.6 vs. 50.4 nmol/L, respectively) and elderly men (111.2 vs.
66.7 nmol/L, respectively). After 12 weeks of resistance training, quadriceps CSA and isometric strength increased
compared to baseline in young (CSA p < 0.0001, strength p = 0.005) and elderly (CSA p = 0.001, strength p < 0.0001)
with no difference between vitamin-D and placebo groups. Vitamin-D intake and resistance training increased
strength/CSA in elderly compared to young (p = 0.008). In the young vitamin-D group, the change in fiber type IIa
percentage was greater after 12 weeks training (p = 0.030) and Myostatin mRNA expression lower compared to the
placebo group (p = 0.006). Neither resistance training nor vitamin-D intake changed VDR mRNA expression.
Conclusion: No additive effect of vitamin-D intake during 12 weeks of resistance training could be detected on either
whole muscle hypertrophy or muscle strength, but improved muscle quality in elderly and fiber type morphology in
young were observed, indicating an effect of vitamin-D on skeletal muscle remodeling.
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During recent years increased attention has been drawn to
the influence of vitamin-D on the development of a var-
iety of diseases. A relationship between vitamin-D insuffi-
ciency and osteoporosis as well as increased risk of bone
fractures has been established [1–4]. Furthermore, low
vitamin-D levels are connected to the development of dia-
betes [5], cardiovascular diseases [3, 6], cancer [3, 7],
depression [3], osteoarthritis [8], multiple sclerosis [9] and
maintenance of a healthy immune system [10], although
the specific mechanisms have not been fully elucidated.
It is well known that both muscle strength and
vitamin-D levels decrease with age [1, 11]. Low vitamin-
D levels are associated with decreased muscle strength
and poor physical function in elderly individuals [12]. In
addition, it has been proposed that vitamin-D plays an
important role for obtaining optimal skeletal muscle
function [13, 14].
Expression of the vitamin-D receptor (VDR) in skeletal
muscle tissue has been questioned [15]. However, recent
data strongly indicate that VDR is expressed in C2C12
myoblasts and myotubes [16, 17], in murine skeletal
muscle [18], and in situ detection of VDR in human skel-
etal muscle points towards a role of vitamin-D on muscle
function [19, 20]. In addition, VDR has been located in
skeletal muscle cells that promote de novo protein synthe-
sis [21]. Addition of the active form of vitamin-D (1,25-
dihydroxyvitamin D3 (1,25(OH)2D3)) to C2C12 myotubes
has been shown to increase skeletal muscle protein
synthesis and Akt/mTOR-signaling [22], down-regulate
the expression of Myostatin and increase the size of
myosin heavy chain (MHC) type II positive myotubes
[17]. Moreover, vitamin-D signaling has been reported to
alter gene expression and increase C2C12 myotube size
[23]. These findings support the hypothesis that vitamin-
D has a direct positive effect on the contractile filaments
and thus muscle strength. Furthermore, preliminary data
from another exercise experiment in our lab suggest that
resistance exercise increases mRNA expression of VDR
and 25-hydroxy vitamin-D (25(OH)D) hydroxylase cyto-
chrome p450 27B1 (CYP27B1), which is responsible for
converting the inactive form of vitamin-D, 25(OH)D, to
the active form, 1,25(OH)2D3, further supporting a posi-
tive role for vitamin-D in skeletal muscle.
Studies in humans have shown positive effects of con-
comitant intake of vitamin-D on muscle strength [24–29]
and intramyonuclear VDR level [30] in vitamin-D insuffi-
cient individuals. Moreover, it has been shown that
vitamin-D intake increases cross sectional area (CSA) of
skeletal muscle fibers [30], the diameter and number of
type II muscle fibers [31] and specifically type IIa fibers
[32]. However, it appears that elderly vitamin-D insuffi-
cient people may benefit the most from vitamin-D intake
[33] whereas young people might not [34].Based on these findings we wanted to examine the hy-
pothesis that vitamin-D is important for the hypertrophic
response to resistance exercise; specifically whether serum
vitamin-D levels may influence the muscular response to
resistance training. UVB radiation from the sun is the
primary source for vitamin-D production and is very low
at northern latitudes from September to April [35]. The
resulting seasonal fluctuations in serum vitamin-D levels
[36] could influence muscle strength and function. If this
is so, it is possible that low serum vitamin-D levels during
the winter months could partly blunt the positive effect of
resistance training, and in such case, vitamin-D supple-
mentation could be important for maximizing improve-
ments in skeletal muscle mass and strength during
resistance training.
The aim of the present study was to investigate whether
vitamin-D intake during 12 weeks of resistance training
has an additive effect on muscle hypertrophy and strength.
We hypothesized that intake of vitamin-D plus calcium
would improve the outcome of three months of resistance
training in healthy untrained individuals resulting in
greater muscle strength and hypertrophy compared to a
training control-group supplemented with calcium alone
(placebo). Moreover, we hypothesized that resistance exer-
cise would increase the mRNA expression of VDR and
CYP27B1. The study included a group of young and a
group of elderly individuals to elucidate a possible blunted
hypertrophic response in the aging muscle.
Materials and methods
Participants
Healthy, sedentary young (aged 20–30 years) and elderly
(aged 60–75 years) Caucasian men living within the local
community in Copenhagen, Denmark, were recruited
through newspaper and web advertisements. Exclusion
criteria were: participation in resistance exercise during
the preceding 6 months, intake of >5 μg vitamin-D
one month prior to the trial period, body mass index
(BMI) <18 or >30, smoking, history of serious knee injury,
any medical condition or medication known to affect
protein turnover, diagnosis or a family history of organic
dysfunctions, cancer, illnesses that could affect the muscu-
loskeletal system, or blood tests values outside normal
range. During the trial period, the participants were told
to refrain from increased exposures to UVB radiation
through e.g. use of solarium or travel activity.
Setting
The study took place at Bispebjerg Hospital, Copenhagen,
Denmark (latitude of 56°N). Inclusion was continuous
from November 17, 2010 to December 21, 2010 and the
last subject completed the study on April 25, 2011. Thus,
the study was conducted in a period of low UVB irradi-
ation from sunlight. Participants were informed about the
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their rights according to the Declaration of Helsinki II. The
study protocol was approved by Research Ethics Commit-
tee Region Hovedstaden Committee F (H-2-2010-100) and
by the Danish Data Protection Agency (2011-41-5965). All
participants gave written informed consent. The study was
registered at ClinicalTrials.gov (nr. NCT01252381).
Randomization and blinding
Participants were continuously randomized by the enve-
lope method. Young and elderly men were randomized
separately. Allocation ratio was 1:1 for vitamin-D and
placebo groups. The subjects were enrolled and random-
ized by the principal investigator. Personnel conducting
the scans, analyzing CSA, measuring isometric muscle
strength, taking biopsies and blood samples, analyzing
muscle fiber type composition and performing RT-qPCR
analyses, were all blinded with respect to allocation.
Interventions
Vitamin-D and calcium supplementation
The participants were randomly assigned (double-blinded)
to a vitamin-D group receiving 48 μg (1920 IU) vitamin-D3
(cholecalciferol)/day plus 800 mg calcium/day or a placebo
group receiving 800 mg calcium/day alone for 16 weeks.
All participants were instructed to take two tablets orally
each day. The vitamin-D-group received one tablet contain-
ing 10 μg vitamin-D3 + 400 mg calcium (Silver, Unikalk,
Frederiksvaerk, DK) and one tablet containing 38 μg
vitamin-D3 + 400 mg calcium (Mega, Unikalk, Freder-
iksvaerk, DK), thus reaching the maximum advisable
daily dose (50 μg, 2000 IU) by the Danish Health and
Medicines Authority. The placebo-group received an
equivalent dose of calcium by consuming two calcium
tablets (400 mg per tablet) (Basic, Unikalk, Frederiksvaerk,
DK). The two tablets were taken simultaneously at the
same time each day together with a meal. Tablets con-
taining vitamin-D plus calcium or calcium alone were
indistinguishable and only labeled with the name of the
manufacturer.
Training protocol
Participants were subjected to 36 training sessions
(12 weeks with 3 sessions/week) consisting of 5–10 min
warm-up on cycle ergometers followed by resistance
training exercises of the lower extremities performed in
commercial knee extension and leg press devices (Tech-
nogym, Super Executive Line, Gambettola, Italy). All ses-
sions were supervised. Progressive loading levels were
monitored continuously and adjusted throughout the
entire training period to maintain muscle loading at the
intended values.
Prior to commencement of training, 1-repetition max-
imum (1RM) strength was estimated from a 5-repetition-maximum (5RM) test [37]. The 5RM test was performed
every two weeks, to ensure that the training load was rela-
tive to the strength progression throughout the training
period. During the first 6 training sessions, participants
completed 3 sets of 12–15 repetitions at 65–70 % of 1RM.
During session 7–12, participants performed 3 sets of 10–
12 repetitions at 70–75 % of 1RM, increasing to 4 sets at
70–75 % of 1RM during session 13–18. From session 19
and onwards, participants performed 5 sets with training
load progressing from 8–10 repetitions at 75–80 % of
1RM in session 19–27 to 6–8 repetitions at 80–85 % of
1RM in session 28–36 [38]. The exercises were performed
in a moderate slow, controlled manner with 1–2 s in the
concentric- and eccentric phase with a rest of 1–3 min be-
tween sets. Exercise compliance (sets, repetitions, and
load) was calculated from daily exercise records completed
by the instructors at each training session. Participants
were informed that a mean attendance of less than 2 train-
ing sessions per week resulted in exclusion. All adverse
events associated with the training intervention were
recorded.
Analyses
CSA of quadriceps muscle
CSA of quadriceps muscle was measured pre (week 0)
and post (week 12) training intervention. Magnetic
Resonance Imaging (MRI) (3.0 T, T1-weighted, Radio-
graphic department, Bispebjerg Hospital, Copenhagen,
Denmark) was conducted to obtain six images starting
at the tibia plateau and proceeding proximally to the
mid/proximal femur. Each slice was 6 mm thick and the
distance between each slice was 54 mm. The slice tan-
gential to the tibia plateau was used as an anatomical
marker (first slice) and the subsequent slices were num-
bered slice-by-slice proximally. The fourth axial slice of
the thigh was selected for further analysis. To avoid any
effect of body fluid disturbances directly related to the
preceding exercise session, the MRI-scans were per-
formed no sooner than 48 h post exercise and before the
biopsies were taken. CSA images of both legs were ana-
lyzed for changes from pre to post training by manually
drawing margins of the quadriceps muscle (Osirix,
open-source 32 bit, Pixmeo SARL, Geneva, Switzerland)
and a mean of both legs was calculated. Images from one
participant were analyzed in succession to ensure uniform
measure technique. Analyses were performed blinded
according to trial group and time point. Whether the pre-
or post picture was analyzed first was randomized.
Isometric muscle strength
All participants were familiarized with the strength test
at inclusion in order to reduce any learning effects.
Isometric knee extension peak torque of both legs was
measured pre and post 12 weeks training with the
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and knees flexed to 90°. To avoid movement or unwanted
contribution of other muscles, participants were strapped
at the hip and the abdomen. A leg cuff, connected to a
strain gauge (Bofors KRG-4, Bofors, Sweden) through a
rigid steel rod perpendicular to the lower leg, was
mounted on the lower leg just above the medial malleolus.
The signal from the strain gauge was amplified (Noraxon
Telemyo 2400 T G2) and sent to a computer to analyze
the greatest force (N) for each participant (Myoresearch,
XP Master Edition 1.07.25). Lever arm was defined as the
distance from the joint line of the knee to the middle of
the leg cuff. After a 5-min warm-up on a cycle ergometer
and 2–3 submaximal pre-test-measurements, each leg was
measured 3 times with 2 min rest between each measure-
ment. Participants were randomized to start with either
the left or the right leg.
On the basis of the quadriceps CSA and isometric
strength measurement, isometric strength/CSA was cal-
culated as an expression of muscle quality.
Serum 25(OH)D concentrations
Blood samples were obtained at baseline (week −4) and
after 0, 2, 6 and 12 weeks of resistance training. Serum
25(OH)D concentrations were determined using an
ELISA-kit (Elecsys, kit ref. 05894913190, Roche Diag-
nostics A/S, Denmark) measuring both 25(OH)D2 and
25(OH)D3 on a Cobas e411 (Roche Diagnostics A/S,
Denmark) at the Department of Clinical Biochemistry,
Bispebjerg Hospital.
Muscle biopsy
A biopsy from the lateral part of the vastus lateralis
muscle from either the left or the right leg was obtained
before the training started (week 0) and after the last
training session (week 12). At week 12, two biopsies
were taken; 4 h (TR+4h) and 48 h (TR+48h) after the
last exercise session, respectively. The biopsies were
obtained using a 4-mm biopsy needle (Bergström,
Stockholm, Sweden). Briefly, the skin was shaved and
disinfected before local anesthetization (1 % lidocaine).
An incision was made through which the muscle biopsy
was taken. Afterwards, the incision was strapped with
SteaStrips and covered with waterproof plaster. The
muscle specimen was quickly freed from any visible
blood, fat or connective tissue and subsequently divided
in two; one piece was mounted in Tissue-Tek and frozen
in precooled isopentane, the other piece was frozen in
liquid nitrogen. Both pieces were stored at −80 °C until
further analysis.
Fiber type analysis
Cross sections (10 μm) were cut from the muscle speci-
men mounted in Tissue-Tek in a cryomicrotome (HM560, Microm, Germany) at −20 °C and stained for myofi-
brillar ATPase at pH 9.4 after both alkaline (pH 10.3)
and acid (pH 4.3 and 4.6) pre-incubations as previously
described [39]. All samples were stained in the same
batch to avoid inter-assay variations. Muscle fiber type
and size were analyzed in a blinded fashion. Only true
horizontal fibers were analyzed for size. Thereby, slightly
fewer fibers could be analyzed for size (202 ± 7 fibers per
biopsy, mean ± SD) than for type (204 ± 4 fibers per
biopsy). As previously described [38], muscle fibers were
characterized as type I, IIa, or IIx based on the ATPase
staining pattern. Tema Image-analyses System (Scan-
beam, Denmark) was used to analyze the cross sections
for muscle fiber type and size. The fiber type distribu-
tions and mean fiber CSA were calculated. Muscle fiber
morphology analysis included determination of fiber
type % and mean CSA. Type IIa and IIx fiber results
were pooled to yield the combined type II fiber area.
Measurement of mRNA
The mRNA expression of VDR, CYP27B1 and Myostatin
was measured using real-time reverse transcriptase poly-
merase chain reaction (RT-PCR). Approximately 20 mg
of muscle tissue was homogenized in 1000 μl TriReagent
(Molecular Research Center, RT 118) using a FastPrep
24 (MP Biomedicals), with muscle tissue placed in a
2 ml microvial with a screw cap (BioSpec) containing
one silicium-carbide crystal and five 2.3 mm steel beads.
Thereafter, 1-Bromo-3-chloropropane (BCP) was added
to the homogenized sample to separate the sample into
an aqueous and an organic phase. The RNA was precipi-
tated from the aqueous phase using isopropanol, washed
with ethanol, and dissolved in RNase-free water. The
RNA was then re-precipitated using sodium acetate
(NaAc), washed in ethanol, and dissolved in RNase-free
water. RNA concentrations and purity were determined
by spectroscopy, and RNA quality was ensured by gel
electrophoresis.
Synthesis of complementary DNA (cDNA) was per-
formed using Omniscript reverse transcriptase (Qiagen,
Hilden, Germany). The cDNA synthesis was performed
on 500 ng of muscle RNA. cDNA was diluted 20 times
in TE-buffer containing 1 ng/μl Salmon DNA. For each
target, 5 μl of diluted cDNA was amplified (25 μl total
volume) in Quantitect SYBR Green Master Mix (Qiagen)
with specific primers (0.1 μM each, Table 1) on a real-
time PCR machine (Stratagene MX3005P, Agilent Tech-
nologies, USA). The thermal profile was set to 95 °C for
10 min, followed by 50 cycles of amplification; 95 °C for
15 s., 58 °C for 30 s., 63 °C for 90 s. Signal intensity was
measured at the 63 °C step, and the threshold cycle (Ct)
values were related to a standard curve made from the
cloned PCR product or corresponding synthetic oligonu-
cleotides. Specificity of the PCR product was confirmed
Table 1 Primers used for real-time reverse transcription PCR
Target Sense primer Antisense primer Ref. sequence
RPLP0 GGAAACTCTGCATTCTCGCTTCCT CCAGGACTCGTTTGTACCCGTTG NM_053275.3
GAPDH CCTCCTGCACCACCAACTGCTT GAGGGGCCATCCACAGTCTTCT NM_002046.4
VDR CAGGCCCAACTCCAGACACACT ATCCAGATTGGAGAAGCTGGACGA NM_000376.2
CYP27B1 AAGCGCAGCTGTATGGGGAGAC GCTCAGGCTGCACCTCAAAATG NM_000785.3
Myostatin TTCGTCTGGAAACAGCTCCTA GGAGTCTCGACGGGTCTCAA NM_005259.2
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cycle (55 °C to 95 °C).
Ribosomal protein large P0 (RPLP0) was chosen as
housekeeping gene. As a control, Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), another often con-
stitutively expressed mRNA, was normalized to RPLP0
(Fig. 1). Changes were seen in GAPDH mRNA expression
when normalized to RPLP0. Most likely this was due to
changes in GAPDH mRNA expression which possibly can
occur due to 12 weeks resistance training. However, a
change in mRNA expression such as that of the house-
keeping genes in Fig. 1 would not affect normalization of
the targets of interest (VDR, CYP27B1 and Myostatin) to
a degree that would explain the differences we see in
mRNA expression of these gene targets.
Statistical analyzes
Based on a previously published article on the effect of
heavy and light load resistance training, respectively, on
muscle growth [40] where the heavy training was equiva-
lent to the training used in this study a power calcula-
tion was carried out to estimate how many subjects
should be included to be able to detect a significant
difference between the desired outcome parameters.
With a power of 0.8 and a significance level at 0.05 we
calculated that a group size of 10 was needed to detect
the expected increase in CSA and strength.
Analyzes were conducted per protocol and separately for
the young and elderly men to explore the effect of vitamin-
D intake vs. placebo. Furthermore, young vs. elderly wasFig. 1 GAPDH mRNA expression normalized to RPLP0. Shown as fold change
at 4 h (TR+4h) and 48 h (TR+48h) after the last exercise session. Results are sh
training (p < 0.05)compared to test differences between age groups. Data
were checked for normality and found to be normally dis-
tributed. Inclusion characteristic results were analyzed
using an unpaired t-test. The results of serum 25(OH)D
concentrations, muscle fiber type composition and gene
expression were analyzed by a two-way analysis of variance
(ANOVA) with repeated measures for time. Serum
25(OH)D concentrations and muscle fiber type compos-
ition are presented as mean ± standard error of the mean
(SEM). Quadriceps muscle CSA, isometric muscle strength
and isometric strength/CSA were calculated as relative
changes from pre to post training and thus presented as
mean percentage-changes ± SEM. Pearson correlation
analyzes were conducted using Prism 6 (GraphPad
Software Inc., CA, USA). Muscle fiber type data are shown
as mean ± SEM. Results of mRNA data post training (TR)
from biopsies taken 4 h (TR+4h) and 48 h (TR+48h) after
the last exercise session are reported relative to the pre
training (week 0) values. The mRNA data are shown as
geometric (Geo) means ± back-transformed SEM. All
mRNA data were log-transformed and normalized to
RPLP0.
Unless otherwise stated, data were analyzed by a two-
way ANOVA with repeated measures for time. When
significant changes were found by ANOVA testing, a
Student-Newman-Keuls post-hoc test was performed.
Level of significance was p < 0.05. For a p-value between
0.05 and 0.1 a tendency was discussed. Statistical ana-
lyzes were conducted using SigmaPlot software version
11.0 unless otherwise stated.s post 12 weeks training compared to pre training on logarithmic scale
own as geometric mean ± back-transformed SEM. * different from pre
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Healthy untrained men, 20 young and 20 elderly, were
included in the study. 6 participants (3 young and 3 eld-
erly), all from the vitamin-D-groups, dropped out. Rea-
sons for dropping out were time consumption (n = 4),
health problem not related to the project (n = 1) and un-
known reason (n = 1). The remaining 34 participants
were included in the final per protocol analysis (Fig. 2).
MRI scans were not performed in one elderly from the
placebo group because of a metal object in his calf.
Baseline characteristics
With the exception of a greater quadriceps CSA and a
lower isometric strength/CSA in the vitamin-D group
compared to the placebo group of elderly men, no sig-
nificant differences between the vitamin-D- or placebo
groups were observed for the baseline characteristics
(Table 2).
Training compliance
The participants completed 12 weeks of training with a
mean training frequency of 2.8 ± 0.2 times (mean ± SD)
per week (with no subjects <2 times/week). For the
young men, the mean training frequencies were 2.9 ± 0.2
and 2.8 ± 0.2 times per week in the vitamin-D and the
placebo group, respectively. For the elderly men, the
mean training frequency was 2.7 ± 0.2 times per week in
both the vitamin-D and the placebo group.Fig. 2 Flowchart showing a young and b elderly subjects from first contacAdverse events
There were no serious injuries or adverse events associ-
ated with the exercise program, but symptoms occurred
in 6 young subjects (3 from the vitamin-D group and 3
from the placebo group) and 9 elderly subjects (4 from
the vitamin-D group and 5 from the placebo group).
The symptoms were usually located to the knee joint but
also pain located in the neck, hip, groin and lumbar back
was recorded. These participants continued exercising
with a lower intensity for a few days to 3–4 weeks. No
dropouts were related to injuries or pain.Serum 25(OH)D concentrations
Vitamin-D and calcium intake commenced 4 weeks
before the training started (week -4). In the young
vitamin-D group, the serum concentrations of
25(OH)D were significantly increased at time-point
0, 2, 6 and 12 weeks as compared to week -4 (Fig. 3).
At time-point 6 and 12 weeks, the serum 25(OH)D
concentrations in the young vitamin-D group were
significantly higher than the placebo group. In the
elderly vitamin-D group, the serum 25(OH)D con-
centrations were significantly increased at time-point
0, 2, 6 and 12 weeks as compared to week -4. At the
same time-points (week 0, 2, 6 and 12 weeks), the
25(OH)D concentrations were significantly higher
than that of the elderly placebo group.t to end of study
Table 2 Inclusion characteristics. Baseline characteristics








Age, years 23.3 ± 2.0 22.4 ± 1.8 0.39
Height, cm 181.6 ± 6.3 181.1 ± 5.5 0.85
Weight, kg 77.9 ± 11.4 75.6 ± 9.1 0.66
Body mass index,
kg/m2
23.6 ± 3.6 23.0 ± 2.3 0.69
CSA, cm2 57.9 ± 9.7 59.0 ± 4.8 0.78
Isometric muscle
strength, Nm
215.6 ± 30.7 209.5 ± 30.5 0.71







Age, years 67.1 ± 2.9 66.6 ± 4.2 0.78
Height, cm 178.5 ± 1.9 178.8 ± 6.7 0.93
Weight, kg 84.8 ± 5.7 80.4 ± 9.3 0.32
Body mass index,
kg/m2
26.6 ± 1.8 25.1 ± 1.1 0.11
CSA, cm2 53.7 ± 2.7 47.0 ± 7.3 0.047
Isometric muscle
strength, Nm
154.6 ± 22.0 168.3 ± 35.3 0.41
Strength/CSA, Nm/cm2 2.89 ± 0.45 3.46 ± 0.49 0.03
Fig. 3 Serum 25(OH)D concentrations. Mean serum 25(OH)D
concentrations ± SEM for young and elderly vitamin-D and placebo
groups. Week 0 denote start of training period. # different from
placebo (p < 0.05). $ different from week −4 (p < 0.05). () denote
tendency (0.05 < p < 0.10)
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All four groups had significant gains in quadriceps
muscle CSA after 12 weeks of resistance training
(Fig. 4a). The changes were 11.3 ± 1.9 % and 7.7 ± 1.8 %
for the young men and 4.9 ± 2.0 % and 8.5 ± 2.8 % for
the elderly men in the vitamin-D and placebo group, re-
spectively. There were no significant differences in CSA
gains between the vitamin-D and placebo groups. When
comparing across age groups no significant differences
were seen in CSA gains (Additional file 1: Table S1).
Isometric muscle strength
All four groups demonstrated significant increases in
quadriceps muscle isometric strength after 12 weeks of
resistance training (Fig. 4b). The changes were 6.3 ± 2.8 %
and 8.9 ± 2.9 % for the young men and 15.0 ± 2.3 % and
8.4 ± 3.4 % for the elderly men in the vitamin-D and pla-
cebo group, respectively. There were no significant differ-
ences in isometric muscle strength gains between the
vitamin-D and placebo groups. Comparing young vs.
elderly men, no significant differences were seen in the
isometric strength gains (Additional file 1: Table S1).
Isometric strength/CSA
No significant increase in the isometric strength/CSA
was seen after 12 weeks resistance training in young orelderly, and no significant differences was seen between
the vitamin-D and placebo groups (Fig. 4c). However, a
tendency towards a main effect of time was seen in the
elderly. Comparing young and elderly, the elderly vitamin-
D group had a greater increase in the % change of isomet-
ric strength/CSA compared to the young vitamin-D group
(Additional file 1: Table S1).
Correlation
No correlations were found between weighted mean
serum 25 (OH) D concentrations (during the 12 week
training period) and mean percentage changes of quadri-
ceps muscle CSA, isometric strength or strength/CSA
(Additional file 2: Figure S1).
Muscle fiber type morphology
By 12 weeks resistance training, the percentage of type
IIa fibers increased and the percentage of type IIx fibers
decreased in both young and elderly (Fig. 5a and 5b).
Fig. 4 CSA, Isometric strength and strength/CSA of Quadriceps muscle. Change in a CSA, b isometric strength and c strength/CSA of quadriceps
muscle for young and elderly vitamin-D and placebo groups, respectively. Data shown as mean percentage change from week 0 ± SEM. * different
from week 0 (p < 0.05)
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only seen in the placebo group. Only in the young men
was a significant increase in fiber type II and type I mean
area seen from pre to post training (Fig. 5c and 5d). In the
elderly, no increase in fiber size was seen. For the elderly,
the p-value for an ANOVA time effect on fiber type IIFig. 5 Fiber type percentage and mean area a and b Fiber type (I, IIa and IIx)
elderly vitamin-D and placebo groups, respectively. Shown as mean fiber type
* different from pre training (p < 0.05). $ different from Placebo group (p < 0.0mean area was 0.074. Comparing young vs. elderly for the
% change in muscle fiber type percentage and mean area
from pre to post training no differences were seen be-
tween age groups, but in the young subjects the vitamin-D
group had a greater increase in type IIa percentage com-
pared to the placebo group (Additional file 1: Table S1).percentage and c and d fiber type (I and II) mean area for young and
percentage ± SEM at pre training (week 0) and post training (week 12).
5)
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All mRNA data were normalized to the pre training
basal mRNA levels. Thus, the mRNA data expresses the
accumulated effect of training (TR) plus the acute effect
after the last training session measured 4 h (TR+4h) and
48 h (TR+48h) post exercise. Importantly, this provided
the opportunity to explore the different mRNA expres-
sion patterns after 12 weeks of vitamin-D supplementa-
tion and resistance training.
No difference in VDR mRNA expression was seen for
any time point or between vitamin-D and placebo
groups for either the young or the elderly men (Fig. 6a).
For the elderly, a tendency was seen towards an in-
creased mRNA expression of VDR at TR+4h compared
to TR+48h (p = 0.069). Comparing young and elderly,
no differences in VDR mRNA expression were seen
(Additional file 3: Table S2).
In elderly, CYP27B1 mRNA expression at TR+48h was
significantly lower in the vitamin-D compared to the pla-
cebo group (Fig. 6b). In the elderly placebo group at week
12, CYP27B1 mRNA expression was significantly increased
when measured 4 h post resistance training (TR+4h) com-
pared to pre training and compared to the vitamin-D
group at the same time point. No significant change in
CYP27B1 mRNA expression was seen in the young men,
but it should be noted that a tendency towards an increase
was seen for TR+4h compared to TR+48h (p = 0.074).
In the placebo group, comparing young and elderly aFig. 6 VDR, CYP27B1 and Myostatin mRNA expression. mRNA expression fo
12 weeks training compared to pre training on logarithmic scale at 4 h (TR
shown as geometric mean ± back-transformed SEM. * different from pre tragreater CYP27B1 mRNA expression was seen in elderly at
48 h post training (TR+48h) (Additional file 3: Table S2).
Myostatin mRNA expression was decreased 4 h post
training (TR+4h) compared to pre training and com-
pared to 48 h post training (TR+48h) for the young and
the elderly men, respectively (Fig. 6c). A difference in
Myostatin mRNA expression was seen between the
vitamin-D and placebo groups for the young men when
measured post training. This difference was not time point
specific. No differences in Myostatin mRNA expression
were seen when comparing young vs. elderly in the
vitamin-D and placebo group, respectively (Additional
file 3: Table S2), but a main effect of time was seen
with Myostatin mRNA expression at TR+4h being
lower than pre training levels and TR+48h being
greater than TR+4h.
Discussion
The current study explores how vitamin-D intake influ-
ences the muscular improvement with 12 weeks resist-
ance training in healthy untrained young and elderly
men. Increased serum 25(OH)D concentrations were
achieved in both the young and the elderly men with
intake of 48 μg vitamin-D3/day, and the serum concen-
trations of 25(OH)D were higher in the vitamin-D
groups compared to the control groups of young and
elderly subjects, respectively. Increases in isometric muscle
strength, muscle hypertrophy, and improved muscle fiberr a VDR, b CYP27B1 and c Myostatin shown as fold changes post
+4h) and 48 h (TR+48h) after the last exercise session. Results are
ining (p < 0.05). $ different from placebo (p < 0.05)
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resistance training. But no differences in muscle strength
or hypertrophy were found between the vitamin-D and
placebo groups in either the young or the elderly men.
However, the elderly vitamin-D group had a greater im-
provement in muscle quality, measured as strength/CSA,
compared to the young vitamin-D group. Importantly, we
found that 12 weeks of vitamin-D supplementation com-
bined with resistance training in the young men lead to a
greater change in Type IIa muscle fiber percentage and
decreased the mRNA expression of Myostatin, which to
our knowledge has not been reported before.
So far, three RCT studies have shown no additive effect
of vitamin-D intake during training in elderly subjects
[26, 41, 42]. However, the subjects in these studies were
heterogeneous and training interventions suboptimal.
Furthermore, the vitamin-D intake was only 10 μg
(400 IU) to 40 μg (1600 IU)/day [26, 41, 42]. Thus, no
overall conclusion on a possible additive effect of
vitamin-D intake can be drawn on the basis of these
studies. The lack of an additive effect of vitamin-D on
skeletal muscle function in elderly with training could
also reflect a blunted response in the aging muscle.
Therefore, in designing this study it was important that
vitamin-D intake and resistance training were optimal
for increasing serum 25(OH)D, and strength and hyper-
trophy parameters, respectively, and that both young and
old subjects were investigated.
Whereas studies have shown muscular improvements
of vitamin-D plus calcium intake [24–29], three studies
on vitamin-D without concomitant calcium supplemen-
tation showed no gain in muscle strength [43–45], sug-
gesting that calcium is a prerequisite for the vitamin-D
effect on skeletal muscle. Furthermore, control groups
receiving calcium supplements alone have shown no
increase in muscle strength. Thus, in the present study
calcium was given to both groups. Calcium absorption is
vitamin-D dependent. Therefore, it cannot be excluded
that calcium plays a role in the skeletal muscles out-
come, along with the proposed effect of vitamin-D.
The optimal dose of vitamin-D supplementation and
optimal serum 25(OH)D concentrations are widely dis-
cussed, and recommendations regarding vitamin-D intake
vary depending on age and grade of sufficiency, ranging
from 10 μg/day in infants to 250 μg/day in adults with
severe insufficiency [46]. But clearly, a dose–response rela-
tionship exists between daily dose and increments in
serum 25(OH)D concentrations [41]. Serum 25(OH)D
concentrations below 50 nmol/L are defined as vitamin-D
insufficiency and concentrations around 90–100 nmol/L
are reported to be optimal for lower extremity strength
[47]. This study examined what effect supplemental
vitamin-D intake might have on a population with suffi-
cient 25(OH)D concentrations and not merely vitamin-D-insufficient subjects. Only the mean serum 25(OH)D
for the young vitamin-D group at baseline (week -4)
showed insufficiency (41.3 ± 7.5 nmol/L), whereas the eld-
erly vitamin-D group had a baseline 25(OH)D concen-
tration of 70.7 ± 16.0 nmol/L. The maximal increase in
serum 25(OH)D concentration in absolute numbers, tak-
ing the variation into account, for the young and elderly
were almost the same (32.8 nmol/L and 40.5 nmol/L,
young and elderly, respectively). As the increase in serum
25(OH)D leveled off in the vitamin-D groups (Fig. 3) the
baseline levels determined the maximal concentration
achieved. Thus, it could be argued that the vitamin-D dose
should have been further increased throughout the study.
However, with the vitamin-D supplementation we did
achieve serum 25(OH)D concentrations for the vitamin-
D groups (maximal concentrations: 74.1 ± 6.6 nmol/L and
111.2 ± 10.2 nmol/L, young and elderly, respectively) that
are expected to be close to optimal for improved muscle
function [48], and a further increase in vitamin-D dose
would have been impossible due to the recommendations
from the Danish Health and Medicines Authority. Import-
antly, the mean serum 25(OH)D concentrations for the
young and elderly placebo groups were significantly lower
(50.4 ± 6.2 and 66.7 ± 7.4 nmol/L, respectively) and thus
suboptimal. Therefore, with the intake of 48 μg/day in the
present study, significant differences in serum 25(OH)D
concentrations between the two groups, vitamin-D and
placebo, were reached thus making it possible to examine
potential differences in the response to resistance training
due to concentrations of 25(OH)D. It should be noted
that applying chromatography-mass spectrometry could
be a more precise method of measuring serum 25(OH)D
than the ELISA-kit used in the current study. However, all
samples were measured at the same time with the ELISA-
kit, which strengthens the data, and most importantly as
vitamin-D3 is given the ELISA-kit includes measurement
of 25(OH)D3.
Significant increases in CSA of quadriceps muscle in
both young and elderly men were achieved. The increase
in CSA in the young and in the elderly men is in line
with the expected outcome of 12 weeks resistance train-
ing [40, 49–52]. A parameter that may affect the meas-
urement of the CSA is the location of the analyzed slice
from the MRI-scan. Therefore, in the present study the
CSA of the quadriceps muscle was measured in the mid-
dle third of the thigh, as the greatest increase is known
to occur in this location [50, 53]. The isometric strength
of the quadriceps muscle increased in the young and the
elderly after 12 weeks of resistance training. The in-
crease for the young men (6.3 ± 2.8 % and 8.9 ± 2.9 %,
vitamin-D and placebo, respectively) is slightly less than
what has been reported previously in resistance training
studies in healthy untrained young men [38, 40],
whereas the increase in the elderly is in line with
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isometric muscle strength into account, we believe that
the training protocol applied has been optimal for gain-
ing skeletal muscle mass and strength. In contrary to
our hypothesis, no evidence for an additive effect of
vitamin-D supplementation was seen on the CSA or iso-
metric muscle strength of the quadriceps muscle in ei-
ther the young or elderly men. It could be argued that
the lack of effects of vitamin-D supplementation is due
to lack of power in the analysis. However, when correlat-
ing the mean serum 25(OH)D concentration throughout
the training period to quadriceps CSA or isometric
strength no correlation was seen, indicating that serum
25(OH)D concentrations within sufficient concentrations
do not affect skeletal muscle hypertrophy or strength im-
provements during resistance training. If muscle strength
increases more than muscle CSA the muscle quality in-
creases, indicating that the present muscle mass has im-
proved the ability to exert muscle force. Thus, calculating
muscle strength/CSA gives an estimate of the muscle qual-
ity. Comparing young and elderly, the elderly vitamin-D
supplemented subjects improved their muscle quality more
than the young vitamin-D group during the 12 weeks
resistance training. This indicates that when performing
resistance exercise, elderly subjects may benefit more from
vitamin-D supplementation than young counterparts.
Muscle fiber type specific hypertrophy in response
to resistance training of both slow-twitch type I fibers
and fast-twitch type II fibers has been shown [55, 56],
but most studies find hypertrophy of primarily type II
fibers [38, 57]. After 12 weeks resistance training, a
muscle fiber type switch occurred from IIx muscle fi-
bers towards IIa muscle fibers (Fig. 5a and 5b). This
is recognized as a normal response to resistance
training. Again, this may indicate that the training
intervention was effectively recruiting even the fastest
motor units (type IIx fibers). In the elderly vitamin-D
group, no decrease in fiber type IIx was seen. This is
most likely caused by a small number of fiber type
IIx at week 0, pre training, thus a significant decrease
was difficult to detect. Increases in the mean area of type
II fibers, but also type I fibers, in the young men also indi-
cate an effective resistance training (Fig. 5c). However, the
elderly men did not show any increase in type I or type II
fiber mean area. From the ANOVA test of type II mean
area in the elderly there was a tendency towards a time-
point effect (p = 0.074), so it can be speculated that the
training period in the present study was too short for the
elderly. Thus, a longer training period for the elderly could
lead to a significant increase in the mean area of type II fi-
bers as seen in the young.
In response to vitamin-D, previous human studies
have reported an effect on the mean area of type II fibers
[31] and fiber type switch from IIx towards IIa [32]. Inthe young men, a significantly greater change in the per-
centage of type IIa fibers was seen in the vitamin-D
group compared to the placebo group, indicating a posi-
tive effect from vitamin-D intake on the muscle fiber
type morphology. However, as previously mentioned this
difference was not translated into significantly greater
muscle strength of the vitamin-D group compared to
the placebo group. It should be noted that in the present
study the improved muscle function has been measured
as isometric muscle strength (force). Therefore, muscle
power (force x speed) rather than muscle strength (force)
could be a more functional measure for improvements in
type II fibers if vitamin-D should have a selective effect on
type II fibers as previously indicated [31, 32].
Myostatin mRNA expression was decreased 4 h after
the last exercise session, which was an expected finding.
Interestingly however, 12 weeks of vitamin-D supple-
mentation decreased the Myostatin mRNA expression
compared to the placebo group in the young men.
Myostatin is a negative regulator of muscle mass, hence
a decrease in Myostatin expression could induce a more
positive balance between skeletal muscle protein synthe-
sis and breakdown. Our finding on Myostatin mRNA
level points towards a positive effect of vitamin-D intake
on skeletal muscle mass and is in line with what has
been seen in C2C12 myoblasts [17, 23]. Decreased
Myostatin mRNA expression due to vitamin-D supple-
mentation was only seen in the young men, thus an
aging effect could exist but needs further investigation.
In contrary to our hypothesis, we did not see any in-
crease in VDR mRNA expression in response to resist-
ance training or in response to vitamin-D intake. Only
the elderly showed a tendency towards an increased
VDR mRNA expression 4 h after the last exercise ses-
sion. The CYP27B1 mRNA expression was decreased in
the elderly vitamin-D group post training. This could
be a negative feedback mechanism from high serum con-
centrations of 25(OH)D (111.2 ± 10.2 nmol/L) for the
elderly vitamin-D group. Thus, the active form of vitamin-
D (1,25(OH)2D3) would be expected to be present in suffi-
cient quantities and thereby decrease the need for the
converting enzyme CYP27B1. The young vitamin-D group
did not show a decrease in CYP27B1 mRNA expression
post training. This may be explained by lower serum
25(OH)D concentrations (71.6 ± 7.1 nmol/L) compared to
the elderly vitamin-D group.
Perspectives
Without any exercise intervention, previous studies have
shown a positive effect of vitamin-D intake on improved
skeletal muscle function [24, 25, 27, 28]. However,
these studies focused on vitamin-D-insufficient subjects,
whereas in the present study the subjects were vitamin-D
sufficient. Our primary findings, muscle strength and
Agergaard et al. Nutrition & Metabolism  (2015) 12:32 Page 12 of 14muscle hypertrophy, are in line with previous studies
on elderly where the additive effect of vitamin-D and
exercise training is examined [26, 41, 42], although the
interventions in those studies have not been optimal
for improving skeletal muscle function. In the present
study, a progressive resistance training protocol was ap-
plied to attain an optimal gain in muscle strength and
mass. Thus, any possible additive effect of vitamin-D
on strength and hypertrophy could be overruled by the
substantial effect of resistance training.
Previous studies seem to indicate that it is important to
monitor vitamin-D levels in frail vitamin-D-insufficient
subjects to maintain skeletal muscle function. This study
indicates that high (vitamin-D groups) or low (placebo
groups) vitamin-D levels within the sufficient range (above
50 nmol/L) results in the same muscle strength and mass
gain from resistance training. Despite the lack of effect on
our primary outcome, we still found that vitamin-D sup-
plementation had a positive effect on muscle quality of the
elderly and muscle fiber type morphology and Myostatin
mRNA expression of the young subjects. This indicates
that vitamin-D is involved in skeletal muscle remodeling
and could be more important for certain age groups or
vitamin-D insufficient subjects. Thus, studies have yet to
elucidate to what extent vitamin-D intake could add to
an improved skeletal muscle function in vitamin-D-
insufficient and frail elderly when applied to resist-
ance training or rehabilitation. Thus, vitamin-D intake
in such subjects could be an important co-factor in
fighting sarcopenia with resistance training.Conclusion
Optimal serum 25(OH)D concentrations for muscle
function improvements were reached in vitamin-D sup-
plemented healthy untrained young and elderly men. Des-
pite this, no additive effect of vitamin-D supplementation
was seen on the increase in quadriceps CSA or isometric
strength from 12 weeks progressive resistance training in
either the young or elderly men. However, vitamin-D in-
take during resistance training increased muscle quality in
elderly men, and improved fiber type morphology and de-
creased Myostatin mRNA expression in young men. The
latter may indicate an effect of vitamin-D on regulation of
skeletal muscle mass, yet further investigations are re-
quired to explore this connection.Additional files
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